ABMT (Advanced BioMedical Technologies) Scaled Net Operating Assets: -21.58 (As of Jul. 2021)


What is Advanced BioMedical Technologies Scaled Net Operating Assets?

Advanced BioMedical Technologies ABMT Scaled Net Operating Assets is -21.58 as of Jul. 2021.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advanced BioMedical Technologies's operating assets for the quarter that ended in Jul. 2021 was $0.39 Mil. Advanced BioMedical Technologies's operating liabilities for the quarter that ended in Jul. 2021 was $8.57 Mil. Advanced BioMedical Technologies's Total Assets for the quarter that ended in Apr. 2021 was $0.38 Mil. Therefore, Advanced BioMedical Technologies's scaled net operating assets (SNOA) for the quarter that ended in Jul. 2021 was -21.58.

Advanced BioMedical Technologies Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Scaled Net Operating Assets Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.32 -49.53 -66.19 -45.66 -34.56

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.23 -26.84 -16.67 -23.98 -21.58

ABMT vs VYCO, ADMT, THMO: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Scaled Net Operating Assets falls into.


Advanced BioMedical Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advanced BioMedical Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2020 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2020 )
=(Operating Assets (A: Oct. 2020 )-Operating Liabilities (A: Oct. 2020 ))/Total Assets (A: Oct. 2019 )
=(0.267-7.836)/0.219
=-34.56

where

Operating Assets(A: Oct. 2020 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.469 - 0.202
=0.267

Operating Liabilities(A: Oct. 2020 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.871 - 0.007 - 0.028
=7.836

Advanced BioMedical Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jul. 2021 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jul. 2021 )
=(Operating Assets (Q: Jul. 2021 )-Operating Liabilities (Q: Jul. 2021 ))/Total Assets (Q: Apr. 2021 )
=(0.39-8.568)/0.379
=-21.58

where

Operating Assets(Q: Jul. 2021 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.397 - 0.007
=0.39

Operating Liabilities(Q: Jul. 2021 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=8.579 - 0 - 0.011
=8.568

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -21.58 mean?
Advanced BioMedical Technologies (ABMT) has a Scaled Net Operating Assets of -21.58 as of Jul. 2021. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Scaled Net Operating Assets too high?
Advanced BioMedical Technologies' current Scaled Net Operating Assets is -21.58.
How does Advanced BioMedical Technologies' Scaled Net Operating Assets compare to VYCO and ADMT?
Advanced BioMedical Technologies' Scaled Net Operating Assets of -21.58 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Scaled Net Operating Assets is -21.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Scaled Net Operating Assets of -21.58. The current Scaled Net Operating Assets is -21.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Scaled Net Operating Assets is -21.58 as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.